Uncovering New Biological Insights Using Advanced Pathology Image Analysis Tools

Presenter: Joseph Krueger, Ph.D. | Vice President, Research and Applications for Advanced Pathology Services, Invicro

In translational research and clinical trials, it is essential to standardize data curation, categorization, analysis and reporting processes. This is important due to the challenges frequently encountered when working with large datasets, including mislabeled slides, transposition errors and inter-observer variability. Here, we will discuss the key steps that need to be considered when organizing pathology datasets and applying advanced analysis applications aimed to provide new insights.

During this webinar, the presenter will:

  1. Discuss the current bottlenecks in developing advanced image analysis workflows on digitized tissue images, including H&E and multiplex IHC and IF
  2. Explain the importance of organizing, standardizing and analyzing tissues with new approaches
  3. Present case examples to demonstrate how using Invicro analysis tools is applied to improve critical points in preclinical and clinical research workflows

Register for On-Demand Access:



Vice President, Research and Applications for Advanced Pathology Services, Invicro

Serving as the scientific leader for Invicro's Advanced Pathology Services, Dr. Krueger is responsible for developing new biomarker applications to meet drug development needs, and provides scientific expertise needed to support sponsor-based projects across therapeutic areas. Prior to joining Invicro, Dr. Krueger was Chief Scientific Officer (CSO) at Flagship Biosciences Inc., where he led the R&D and Scientific efforts in applying novel quantitative tissue image analysis approaches to immuno-oncology and rare diseases to support drug and companion diagnostic development. Prior to Flagship, he served in senior scientific roles in oncology drug development for OSI Pharmaceuticals in Boulder, CO and Pfizer in Andover, MA. Dr. Krueger completed his postdoctoral fellowship at The Scripps Research Institute and The University of California, San Diego after completing his Ph.D. in Cancer Biology at Wayne State University in Detroit, MI.